Results 11 to 20 of about 30,065 (206)

Pathogenicity and virulence of Shigella sonnei: A highly drug-resistant pathogen of increasing prevalence [PDF]

open access: yesVirulence, 2023
Shigella spp. are the causative agent of shigellosis (or bacillary dysentery), a diarrhoeal disease characterized for the bacterial invasion of gut epithelial cells.
Xosé Manuel Matanza Fente   +1 more
exaly   +5 more sources

Macrolide-Resistant Shigella sonnei

open access: yesEmerging Infectious Diseases, 2008
Shigella sonnei UCN59, isolated during an outbreak of S. sonnei in January 2007, was resistant to azithromycin (MIC 64 mg/L). The isolate contained a plasmid-borne mph(A) gene encoding a macrolide 2′-phosphotransferase that inactivates macrolides ...
Leyla Boumghar-Bourtchai   +7 more
doaj   +6 more sources

Shigella sonnei O-Antigen Inhibits Internalization, Vacuole Escape, and Inflammasome Activation [PDF]

open access: yesmBio, 2019
Two Shigella species, Shigella flexneri and Shigella sonnei, cause approximately 90% of bacterial dysentery worldwide. While S. flexneri is the dominant species in low-income countries, S.
Jayne L. Watson   +6 more
doaj   +2 more sources

Genome-wide analysis exploring mechanisms used by Shigella sonnei to survive long-term nutrient starvation [PDF]

open access: yesmSystems
Shigella is a major cause of severe diarrhea, with Shigella flexneri and Shigella sonnei accounting for over 90% of infections. Progressive economic growth worldwide correlates with the replacement of S. flexneri by S.
Xosé M. Matanza   +6 more
doaj   +2 more sources

Protective immunity against Shigella sonnei in vaccinated and challenged adult Thai volunteers [PDF]

open access: yesmSphere
A safe, effective, and affordable vaccine that can prevent Shigella-induced diarrhea could have a significant impact on reducing morbidity and mortality in populations at risk.
Esther Ndungo   +7 more
doaj   +2 more sources

Development and evaluation of a dual-target glycoconjugate against Shigella sonnei [PDF]

open access: yesFrontiers in Immunology
IntroductionShigellosis morbidity and mortality, combined with the increase in multidrug-resistant infections, make Shigella vaccine development a global imperative.
Catherine L. Hall   +6 more
doaj   +2 more sources

Shigella sonnei [PDF]

open access: yesTrends in Microbiology, 2020
Shigella sonnei is a rod-shaped, Gram-negative facultative intracellular pathogen. It was named ‘Sonne’s bacillus’ after Carl Olaf Sonne who described it as a causative agent of bacillary dysentery. S.
Torraca, Vincenzo   +2 more
core   +8 more sources

Shigella sonnei: virulence and antibiotic resistance [PDF]

open access: yesArchives of Microbiology, 2020
Shigella sonnei is the emerging pathogen globally, as it is the second common infectious species of shigellosis (bloody diarrhoea) in low- and middle-income countries (LMICs) and the leading one in developed world. The multifactorial processes and novel mechanisms have been identified in S. sonnei, that are collectively playing apart a substantial role
Ahtesham Ahmad Shad, Wajahat Ahmed Shad
exaly   +3 more sources

Shigella sonnei infection of zebrafish reveals that O-antigen mediates neutrophil tolerance and dysentery incidence. [PDF]

open access: yesPLoS Pathogens, 2019
Shigella flexneri is historically regarded as the primary agent of bacillary dysentery, yet the closely-related Shigella sonnei is replacing S. flexneri, especially in developing countries.
Vincenzo Torraca   +12 more
doaj   +13 more sources

Shigella flexneri and Shigella sonnei among children under five in Kenya’s urban informal settlement [PDF]

open access: yesGut Pathogens
Background Shigella species are a significant global public health threat with the highest burden of Shigella-associated diarrhoea in children under five years of age, particularly in low- and middle-income countries. Given the high burden of shigellosis
Christine Kioko   +12 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy